NEW
YORK, June 26, 2024 /PRNewswire/ -- The global
influenza diagnostics market size is estimated to grow by
USD 517.5 million from 2024-2028,
according to Technavio. The market is estimated to grow at a CAGR
of about 7.22% during the forecast period. Rising
incidence of influenza is driving market growth, with a
trend towards rising approvals for influenza diagnostic
products. However, lack of laboratory infrastructure in
developing regions poses a challenge. Key market players
include Abbott Laboratories, Becton
Dickinson and Co., BICO Group AB, Bio Rad Laboratories Inc.,
Biocartis NV, bioMerieux SA, Danaher Corp., DiaSorin SpA, F.
Hoffmann La Roche Ltd., Hologic Inc., Princeton BioMeditech Corp.,
QIAGEN NV, Quidelortho Corp., Response Biomedical Corp., SA
Scientific Ltd., Sd Biosensor Inc., Sekisui Chemical Co. Ltd.,
Siemens Healthineers AG, Tecan Trading AG, and Thermo Fisher
Scientific Inc..
![Technavio has announced its latest market research report titled Global influenza diagnostics market 2024-2028 Technavio has announced its latest market research report titled Global influenza diagnostics market 2024-2028](https://mma.prnewswire.com/media/2447491/IRTNTR44375_bw2.jpg)
Get a detailed analysis on regions, market
segments, customer landscape, and companies- View the
snapshot of this report
Influenza
Diagnostics Market Scope
|
Report
Coverage
|
Details
|
Base year
|
2023
|
Historic
period
|
2018 - 2022
|
Forecast
period
|
2024-2028
|
Growth momentum &
CAGR
|
Accelerate at a CAGR of
7.22%
|
Market growth
2024-2028
|
USD 517.5
million
|
Market
structure
|
Fragmented
|
YoY growth 2022-2023
(%)
|
6.6
|
Regional
analysis
|
North America, Europe,
Asia, and Rest of World (ROW)
|
Performing market
contribution
|
North America at
34%
|
Key
countries
|
US, China, Germany,
France, and Canada
|
Key companies
profiled
|
Abbott Laboratories,
Becton Dickinson and Co., BICO Group AB, Bio Rad Laboratories Inc.,
Biocartis NV, bioMerieux SA, Danaher Corp., DiaSorin SpA, F.
Hoffmann La Roche Ltd., Hologic Inc., Princeton BioMeditech Corp.,
QIAGEN NV, Quidelortho Corp., Response Biomedical Corp., SA
Scientific Ltd., Sd Biosensor Inc., Sekisui Chemical Co. Ltd.,
Siemens Healthineers AG, Tecan Trading AG, and Thermo Fisher
Scientific Inc.
|
Market Driver
The global influenza diagnostics market is experiencing growth
due to vendors' focus on creating compliant diagnostic products.
Regulatory bodies like the FDA, EMA, and CFDA have led to an
increase in product approvals. Rapid influenza diagnosis is in high
demand, leading to a surge in nucleic acid detection
technique-based product clearances. Hologic's Panther Fusion
SARS-CoV-2/Flu A/B/RSV assay, recently granted FDA clearance, is an
example of this trend. This molecular diagnostic test detects and
distinguishes four common respiratory viruses, contributing to
market expansion.
The Influenza Diagnostics Market is experiencing significant
growth due to the increasing demand for rapid and accurate
diagnostic tests. The market is driven by the need to identify and
treat influenza cases early to prevent the spread of the virus.
Technologies such as rapid antigen detection and molecular
diagnostics are gaining popularity for their speed and accuracy.
Additionally, the ongoing COVID-19 pandemic has highlighted the
importance of diagnostic testing in public health, leading to
increased investment in this area. The market is expected to
continue growing in the coming years as new technologies and
innovations are developed. Key players in the market include
manufacturers of diagnostic tests and equipment, as well as
healthcare providers and research institutions.
Research report provides comprehensive data on
impact of trend. For more details- Download a Sample
Report
Market Challenges
- Developing countries encounter difficulties in establishing and
maintaining advanced influenza diagnostic laboratories. Inadequate
infrastructure, insufficient trained personnel, and limited
availability of diagnostic tools and reagents hinder timely and
accurate diagnosis. This results in lower testing capacity compared
to demand, leading to delays in diagnosis and treatment. Remote
areas with inadequate laboratory facilities further complicate
disease surveillance and response to influenza outbreaks,
negatively impacting the global influenza diagnostics market
growth.
- The Influenza Diagnostics Market faces several challenges in
providing accurate and timely results. Pathogens such as influenza
require specific diagnostic tests to identify them. Urgent need for
rapid testing is crucial to prevent the spread of infection.
However, challenges like high cost, complexity, and low sensitivity
of current diagnostic methods persist. Technological advancements
like PoCT (Point of Care Testing) and digital diagnostics are being
explored to address these issues. The market also requires
regulatory approval and reimbursement policies to support the
adoption of new diagnostic technologies. The need for continuous
innovation and improvement in diagnostics is essential to meet the
demands of public health and healthcare systems.
For more insights on driver and
challenges - Request a sample report!
Segment Overview
This influenza diagnostics market report extensively covers
market segmentation by
- End-user
- 1.1 Hospitals and diagnostic laboratories
- 1.2 Academic and research centers
- 1.3 Homecare
- Type
- 2.1 Point-of-care testing
- 2.2 Immunodiagnostics
- 2.3 Molecular diagnostics
- Geography
- 3.1 North America
- 3.2 Europe
- 3.3 Asia
- 3.4 Rest of World (ROW)
1.1 Hospitals and diagnostic laboratories- The
hospital and diagnostic laboratories segment is a major player in
the global influenza diagnostics market. Influenza diagnostics
involve tests to detect and diagnose influenza infections, with a
focus on hospital and lab settings. With influenza being a
contagious respiratory illness affecting millions annually,
efficient and accurate diagnostic tools are crucial for healthcare
providers. Advanced technologies like rapid antigen tests,
molecular assays, and serological tests enable prompt diagnosis and
effective patient management. These advancements are expected to
fuel market growth during the forecast period.
For more information on market segmentation with
geographical analysis including forecast (2024-2028) and historic
data (2017-2021) - Download a Sample Report
Research Analysis
The Influenza Diagnostics Market encompasses various diagnostic
tools and technologies used for the detection of influenza
infection in severe illness cases leading to respiratory deaths.
The World Health Organization emphasizes the importance of timely
and accurate diagnosis to facilitate appropriate medical procedures
and interventions. Product segmentation includes Diagnostic
technologies, such as Viral culture tests and Serology tests, used
in Research industries and Diagnostic laboratories. Molecular
diagnostics, including Rapid antigen tests and Molecular tests, are
gaining popularity due to their high sensitivity and specificity.
However, these advanced diagnostic tools may yield false-negative
or false-positive results, necessitating a regulatory framework to
ensure their accuracy. Traditional diagnostic tests, like Rapid
diagnostic tests, are also used extensively in Hospitals and
clinics by healthcare professionals to diagnose and treat influenza
infections. The healthcare sector continues to invest in innovative
diagnostic tools to improve patient outcomes and reduce the burden
of influenza-related illnesses.
Market Research Overview
The Influenza Diagnostics Market refers to the industry
dedicated to the production, development, and distribution of
diagnostic tools and tests used to identify influenza viruses.
These diagnostics play a crucial role in disease management and
prevention, particularly during outbreaks and epidemics. Influenza
diagnostics encompass various technologies such as rapid antigen
detection tests, reverse transcription polymerase chain reaction
(RT-PCR), and viral culture. These tests provide essential
information for accurate diagnosis, enabling timely treatment and
infection control measures. The market for influenza diagnostics is
driven by factors such as increasing global awareness of influenza
and its complications, the need for rapid and accurate diagnostic
tools, and ongoing research and development in the field.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
- End-user
-
- Hospitals And Diagnostic Laboratories
- Academic And Research Centers
- Homecare
- Type
-
- Point-of-care Testing
- Immunodiagnostics
- Molecular Diagnostics
- Geography
-
- North America
- Europe
- Asia
- Rest Of World (ROW)
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory
company. Their research and analysis focuses on emerging market
trends and provides actionable insights to help businesses identify
market opportunities and develop effective strategies to optimize
their market positions.
With over 500 specialized analysts, Technavio's report library
consists of more than 17,000 reports and counting, covering 800
technologies, spanning across 50 countries. Their client base
consists of enterprises of all sizes, including more than 100
Fortune 500 companies. This growing client base relies on
Technavio's comprehensive coverage, extensive research, and
actionable market insights to identify opportunities in existing
and potential markets and assess their competitive positions within
changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download
multimedia:https://www.prnewswire.com/news-releases/influenza-diagnostics-market-size-is-set-to-grow-by-usd-517-5-million-from-2024-2028--rising-incidence-of-influenza-boost-the-market-technavio-302182803.html
SOURCE Technavio